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SUMMARY
With indirect immunofluorescetice techniques we demonstrated that recombinant gamma-
interferon induced the expression of the class II antigens HLA-DR and HI.A-DQ as well as
intercellular adhesion molecule-i (ICAM-i) on normal, cultured human keratinocytes grown
in low-calcium, serum-free medium. Each antigen displayed a distinctive cellular staining
pattern. HLA-DR was strongly localized to perinuclear zones with intense cell surface
expression; HLA-DQ displayed a perinuclear accentuation, but with minimal cell surface
staining, and ICAM-i was strongly expressed in a diffuse cytoplasmic pattern with intense cell
surface expression. Keratinocytes grown in medium supplemented with 10",, fetal calf serum
underwent differentiation, with a diminished expression of all three antigens as compared to
those grown in low-calcium, serum-free medium.
These results confirm that gamma interferon can differentially regulate HLA-DR and HLA-
DQ expression; that there are probably different biochemical metabolic pathways by which
these three molecules are expressed on keratinocytes, and that the expression is also a function of
the degree of keratinocyte differentiation. The strong cell surface expression of ICAM-i is
suggested to be of major importance as the recognition molecule, by which T cells bind to
gamma interferon exposed keratinocytes, and suggests an integral role for this molecule in
epidermal lymphocyte trafficking.
The human class II major histocompatibility complex (MHC) antigens are coded for by three
distinct loci on chromosome six: HLA-DR, HLA-DQ and HLA-DP.' Unlike class I MHC
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antigens, which are ubiquitously expressed, class 11 antigens have a limited cellular distribution
on human nucleated cells.""^ HLA-DR expression on macrophages is necessary for antigen to be
presented to T lymphocytes/ and for induction of cytolytic T lymphocyte activity,*^ and is
involved in the autologous mixed lymphocyte reaction (AMLR).^ Much less is known about the
functional significance of HLA-DQ. However, it has similar effects to HLA-DR and Gonwa et
alJ have shown it to be required for antigen presentation in the AMLR. In normal skin, both
HLA-DR and HLA-DQ are found on the same cells, namely vascular endothelium,**
Langerhans cells'* and the acrosyringial epithelium.'^ Under normal circumstances neither
antigen is expressed by keratinocytes (KC).^^ In diseased skin, particularly the inflammatory
dermatoses, HLA-DR is commonly expressed by KC' ^ and has been related to the presence of
intra-epidermal lymphocytes.'' HLA-DQ expression by KC is infrequent although it has been
observed in cutaneous T cell lymphoma, lichen planus,'** Sorr^/ia-induced skin disease,'^ and
allergic and irritant contact dermatitis.'*'
Gamma interferon IFN-y, induces HLA-DR expression on normal cultured human KC'^
and direct intradermal injection of IFN-7 will induce the appearance of HLA-DR on the
overlying epidermal KC.' ̂  However, IFN-v has not been demonstrated to induce HLA-DQ on
normal cultured human KC'"* or on KCs in a short-term organ culture system.' '-̂ ^
Intercellular adhesion molecule-i (ICAM-i) is a cell surface glycoprotein of molecular
weight 90-114 kd expressed by both haemopoeitic and non-haemopoeitic cells.^''^^ It is
involved in the regulation of lymphocyte-cell adherence mediated by lymphocyte function-
associated antigen-i (LFA-i) which is a ligand for ICAM-i.^^ The adherence of resting and
activated autologous and allogeneic T lymphocytes to IFN-y treated KC is blocked by anti-
LFA-i antibodies^* '̂̂ ^ or anti-ICAM-i antibody,̂ *" thus implying a role for ICAM-i in
lymphocyte-KC interactions in the inflammatory dermatoses.
We have investigated the cellular distribution patterns of HLA-DR, HLA-DQ and ICAM-i
in normal human cultured KC in serum-free and serum-supplemented medium and the effect of
IFN-y on the expression of these antigens.
METHODS
Preparation of keratmocyte cultures
Samples of normal human skin were obtained from patients undergoing cosmetic surgery and
single cell suspensions prepared according to the method of Liu and Karasek.^^ Small, round,
viable cells were seeded onto and grown in either 10 cm diameter Petri dishes (Lux Flow
Laboratories, Inc) or Lab-Tek chamber slides (Miles Scientific, Inverhill, IL, U.S.A.) in either
a serum-free KC growth medium containing low calcium^^ (KGM, Clonetics, CO., San Diego,
CA, U.S.A.) or Dulbecco's modified Eagle's medium (DMEM, Gibco Laboratories, Grand
Island, NY) supplemented with io'\, heat inactivated fetal calf serum (FCS, Gibco). Cells were
maintained in a humidified incubator in 5",, Co2/95"() air at 37 C and used after passage 3.
Rccombinant IFN-7 (specific activity^ i 7 x 10̂  U/mg; kindly provided by Dr M.Shepard,
Genentech Inc., South Francisco, CA, U.S.A.) was used at a final concentration of 1200 U/ml
and added to dishes or slides containing sub-confluent KC, after which incubation was
continued for 3 days at 37 C.
Staining of keratinocyte for HLA-DR, HLA-DQ and ICAM-i
KC in Lab-Tek chamber slides were either fixed for 15 min in acetone at 4' C to permeabilize the
cell membrane prior to staining, or were left unfixed . The KC monolayers were incubated for 25
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min on ice with lo/^g/ml of the panel of monoclonal antibodies listed in Table i. OKT8 was used
as an isotype irrelevant control antibody. The cells were washed and then stained with i /ig of
fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (Tago Inc., Burlingame, CA,
U.S.A.). In order to investigate the possibility of anti-HLA-DQ antibody binding to HLA-DR
antigen, which may have been altered after acetone fixation,^^ KC were stained directly with
FITC-conjugated Leu 10 (Becton Dickinson, Mountain View, CA, U.S.A.) for 25 min on ice
and compared with KCs pre-incubated with TS i • 16 for i h on ice prior to staining with FITC-
conjugated Leu 10. The cells were examined using an Olympus BH-2 fluorescence microscope.
Cultured KC were trypsinized using 003"o trypsin/ooi",, EDTA, an aliquot of 10'' KC was
stained as described above, and staining intensity and numbers of cells stained determined using
fluorescence activated cell sorter (Epics 541: Coulter Corp), as previously described.'^
RESULTS
Induction of HLA-DR, HLA-DQ and ICAM-i antigen expression by IFN-y
Normal human KC grown in KGM in the absence of IFN-y did not express HLA-DR, HLA-
DQ or ICAM-I. However, the addition of IFN-y (1200 U/ml) induced distinct patterns of
cellular expression for all three antigens. The staining patterns described combine the cell
surface staining seen in the absence of fixation or permeabilization, and the intracellular staining
seen after acetone treatment.
HLA-DR was localized to the perinuclear zone with intense cell suface expression (Fig. i), as
has been observed previously.~^" HLA-DQ showed perinuclear localization, but with minimal
cell surface staining (Fig. 2). ICAM-i was strongly expressed in a diffuse cytoplasmic pattern
with intense cell surface expression (Fig. 3). Using FITC-conjugated Leu 10 (anti-HLA-DQ)
there was no observable inhibition of staining when the KC were pre-incubated with TS 116,
suggesting that the Leu 10 antibody was not binding to HLA-DR antigen (data not shown).
This was also confirmed by the difference in the intensity of cell-surface staining between HLA-
DR and HLA-DQ.
Effect of serum-supplemented medium on the IFN-y-induced expression of HLA-DR, HLA-DQ
and ICAM-I
All three antigens were expressed less strongly on KC cultured DMEM-l- io"o FCS than on
cells cultured in KGM. The cell surface expression of ICAM-i and HLA-DR was similar to
that seen on KC cultured in KGM, but the intracellular staining was markedly reduced (data
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FIGURE I. IFN-y-itiduced expression of HLA-DR on acetone-fixed keratinocytes showing
perinudear and intense cell surface staining (original x 150).
FIGURE 2. IFN-)'-induced expression of HLA-DQ on acetone-fixed keratinocytes showing
perinudear and minimal ceil surface staining (origitial x 150).
not shown). There was no cell surface expression of HLA-DQ on KC cultured in
DMEM + io"i, FCS and the intracellular staining was also markedly reduced.
Intensity of cell surface expression of HLA-DR, HLA-DQ and ICAM-i antigens using FACS
analysis
After subtraction of OKT8 staining (which was used as the IgGi isotype control) background
values, the mean channel readings for the three antigens studied were: HLA-DQ: 18, HLA-DR:
52 and ICAM-i: 79.
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FIGURE 3. IFN-j'-induced expression {i! i t ,AM-i an accKmc-tixcd kcrannocyiL-s showing intense
cell surface and difFuse cytoplasmic staining (original x 150).
These values are for KC grown in KGM supplemented with IFN-;' (i 200 U/ml) for 3 days. In
the absence of IFN-y, the mean channel readings were 0 for all three antigens, as well as for the
0KT8 stained KC. It is important to use isotype controls because we have previously observed
that IFN-y induces expression of Fc receptors in cultured KC.' "̂  It should also be noted that the
mean channel readings presented are on a log scale; thus the values represent a considerable
degree of fluorescence intensity.
DISCUSSION
This study has demonstrated the ability of IFN-y to induce contrasting and distinctive cell
surface and intracellular expression of HLA-DR, HLA-DQ and ICAM-i antigens in
keratinocytes. The expression of these antigens was diminished by growing the KC in medium
supplemented with serum. The induction of HLA-DQ by IFN-y is of interest as Basham et al.' ̂
in a previous study, were unable to demonstrate this antigen on normal human KC. This
disparity can be explained by the fact that they cultured KC in DMEM + io'\, FCS which we
have shown to abrogate the cell surface expression of HLA-DQ. The observed reduction in
IFN-y-induced antigen expression in serum-supplemented medium was most probably a result
of the greater degree of KC differentiation observed under these culture conditions.
The rarity of HLA-DQ expression on keratinocytes in vivo could well be because of the
intracellular localization of this molecule which may not be detected by conventional staining
techniques. It has been demonstrated that the cell surface expression of HLA-DR is five times
greater than that of HLA-DQ,^^ and shedding of the HLA-DQ molecule has also been
postulated as a reason for its limited cell surface occurrence.^' Even in the inflammatory
dermatoses, characterized by intense KC expression of HLA-DR, the concomitant appearance
of HLA-DQ is unusual, and to date has only been observed in cutaneous T cell lymphoma,
lichen planus,'"* Borrelia-'induccd skin disease,' ̂  and allergic and irritant contact dermatitis.' ̂
This may be a marker of different KC function in these diseases, but is more probably a result of
6 C.E.M.Griffiths, J3 Voorhees and B.J.Nickoloff
higher concentrations of IFN-y produced by dermal or intra-epidermal activated T lympho-
cytes in these particular dermatoses. An analogous situation has been observed in auto-immune
thyroid disease where in class II antigen expression by thyrocytes HLA-DR is more commonly
and intensely expressed than HLA-DQ.^'^ The same pattern is seen in cultured thyrocytes
treated with IFN-"/.^^ Measurement of steady-state mRNA levels transcribed from different
HLA-DQ loci may allow further identification of the genes upon which IFN-y acts in human
KC. Further study of the regulation of HLA-DQ is required since one allele (HLA-DQ/0 has
recently been found to be associated with pemphigus vulgaris.^^ Furthermore, HLA-DQ
expression by lymphoid cells has been associated with antigen-specific suppression of the
immune response. ̂ ^̂  Since IFN-y treated KCs have also been observed to induce antigen-
specific unresponsiveness,^^ it will be of interest to determine whether such reactions are
mediated via HLA-DQ.
The ability of IFN-7 to induce ICAM-1 expression on the surface of KC and the intense cell
surface expression of this antigen is of major importance in the lymphocyte-KC adherence
reaction in vitro~'*'^^ and may also be relevant in many inflammatory dermatoses in vivo}'' It has
been demonstrated that anti-LFA-i and anti-ICAM-i antibodies, but not anti-HLA-DR
antibodies, inhibit the binding of T lymphocytes to IFN-y-treated KC"'*" '̂' thus producing
additional evidence that ICAM-i is involved in this process. The prominent cell-surface
expression of this antigen by KC after IFN-y exposure supports this idea.
Thus, it is postulated that activated T lymphocytes in the dermis induce ICAM-i expression
on KC by means of IFN-7 production. The present work extends our previous suggestion that
IFN-"; is the common molecule responsible for the expression of HLA-DR on KC in a variety of
inflammatory dermatoses.**" ICAM-i expression of KC could promote lymphocyte-KC
adherence reactions and the subsequent events leading to class II antigen induction on KC,
which may contibutc to the pathophysiological changes observed in a variety of inflammatory
dermatoses.'^
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